Mirena 52 MG systems
Ended Awarded
- Contract number
- SPE2DB26FQWLM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,083
Award facts
- Contract value 100% obligated
- $2,083.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,083.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Mirena 52 mg contraceptive systems. The award, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, utilizes firm fixed-price pricing with no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which was recently awarded on November 13, 2025, with a ceiling value of $499,999,999 and performance through December 31, 2036.
The PPV-G GEN V program represents a comprehensive $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors capable of supplying the full spectrum of pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. Under this framework, DMS Pharmaceutical Group's contract structure includes a 30-month base period with three optional 30-month renewal periods, positioning the company as a critical pharmaceutical supplier for military medical operations. The delivery order for Mirena systems exemplifies the company's role in fulfilling specialized pharmaceutical requirements across diverse therapeutic categories to support recurring medical supply needs of the federal military medical system.
Quick answers
Who was awarded contract SPE2DB26FQWLM?
SPE2DB26FQWLM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DB26FQWLM worth?
The government has obligated $2,083 on SPE2DB26FQWLM.
Is contract SPE2DB26FQWLM an order under another contract?
Yes. SPE2DB26FQWLM is a delivery order under SPE2DB25D9321, an indefinite delivery contract.
Was contract SPE2DB26FQWLM competed?
The extent of competition for SPE2DB26FQWLM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award